NOV
45
-2
AEP
61
2
FLR
43
-3
PFE
40
3
JWN
73
-3
AMT
71
6
CA
44
8
EXR
59
4
SLG
66
-3
ROP
71
6
BBY
50
-2
HPE
50
14
BRK.B
47
4
FOX
51
-6
AAL
50
2
TRV
45
-4
EMC
89
4
CAG
47
-3
EBAY
47
2
KR
50
-2
NOV
45
-2
AEP
61
2
FLR
43
-3
PFE
40
3
JWN
73
-3
AMT
71
6
CA
44
8
EXR
59
4
SLG
66
-3
ROP
71
6
BBY
50
-2
HPE
50
14
BRK.B
47
4
FOX
51
-6
AAL
50
2
TRV
45
-4
EMC
89
4
CAG
47
-3
EBAY
47
2
KR
50
-2
Financhill
Back

Protagonist Therapeutics Vs. Akebia Therapeutics Industry Stock Comparison

Buy
75

PTGX
Protagonist Therapeutics

Last Price:
31.75
Seasonality Move:
16.08%
Sell
42

AKBA
Akebia Therapeutics

Last Price:
1.18
Seasonality Move:
-7.41%
Buy
75
Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $31.47. The Score for PTGX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • PTGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.18. The Score for AKBA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • AKBA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $31.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.65 Buy
Relative Strength Index (14 RSI): 73.98 Buy
Chaikin Money Flow: 221485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.05 - 28.27) Buy
Bollinger Bands (100): (24.5 - 29.26) Buy

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 37.32 Sell
Chaikin Money Flow: -1405102 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.27 - 1.43) Sell
Bollinger Bands (100): (1.3 - 1.72) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.24 Buy
20-day SMA: 26.68 Buy
50-day SMA: 27.75 Buy
200-day SMA: 22.28 Buy
8-day EMA: 28.73 Buy
20-day EMA: 27.56 Buy
50-day EMA: 27.23 Buy
200-day EMA: 23.97 Buy

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.31 Sell
20-day SMA: 1.33 Sell
50-day SMA: 1.52 Sell
200-day SMA: 1.32 Sell
8-day EMA: 1.27 Sell
20-day EMA: 1.34 Sell
50-day EMA: 1.43 Sell
200-day EMA: 1.33 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $3.70 per share, and a decrease next year of $1.31 per share.

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.05 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):